Hoff, Benjamin A.
Pompe, Esther
Galbán, Stefanie
Postma, Dirkje S.
Lammers, Jan-Willem J.
ten Hacken, Nick H. T.
Koenderman, Leo
Johnson, Timothy D.
Verleden, Stijn E.
de Jong, Pim A.
Mohamed Hoesein, Firdaus A. A.
van den Berge, Maarten
Ross, Brian D.
Galbán, Craig J.
Article History
Received: 18 August 2016
Accepted: 20 April 2017
First Online: 7 June 2017
Competing Interests
: E.P. has received an unrestricted educational grant for research from Astra Zeneca and Chiesi; fees for consultancies by E.P. were given to the University of Groningen by A.Z., Boehringer Ingelheim, Chiesi, G.S.K., Nycomed and TEVA. N.H.T.t.H. received grants from GlaxoSmithKline, Boehringer Ingelheim, Nycomed and Chiesi. C.J.G., B.D.R. and B.A.H. have a financial interest in the underlying patented University of Michigan technology licensed to Imbio, L.L.C., a company in which B.D.R. has a financial interest. S.G., P.A.d.J., F.A.A.M.H., L.K., T.D.J., and M.v.d.B. have no competing interests.